Mask Use on Public Transportation Through 4-18

Community NewsNews
648

Translate to Spanish or other 102 languages!

At CDC’s recommendation, TSA will extend the security directive for mask use on public transportation and transportation hubs for one month, through April 18th. Image for illustration purposes
At CDC’s recommendation, TSA will extend the security directive for mask use on public transportation and transportation hubs for one month, through April 18th. Image for illustration purposes

Mega Doctor News

- Advertisement -

CDC – At CDC’s recommendation, TSA will extend the security directive for mask use on public transportation and transportation hubs for one month, through April 18th.

During that time, CDC will work with government agencies to help inform a revised policy framework for when, and under what circumstances, masks should be required in the public transportation corridor. This revised framework will be based on the COVID-19 community levels, risk of new variants, national data, and the latest science. We will communicate any updates publicly if and/or when they change.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Severe Cases of COVID-19 can Impact the Kidneys
Next article
Properly Dispose of Prescription Medications

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.
- Advertisement -